Market Research Report
South and Central America Continuous Positive Airway Pressure (CPAP) Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Automatic, Manual); End User (Emergency Health Departments, Hospitals), and Country
|South and Central America Continuous Positive Airway Pressure (CPAP) Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Automatic, Manual); End User (Emergency Health Departments, Hospitals), and Country|
Published: November 17, 2020
The Insight Partners
Content info: 86 Pages
Delivery time: 1-2 business days
South & Central America continuous positive airway pressure (CPAP) devices marketis expected to reach US$ 410.05millionby 2027 from US$ 238.30 million in 2019. The market is anticipated to grow with a CAGR of 7.1% from 2020 to 2027.
Growing aging population and rising respiratory disorders are expected to witness rapid growth for theSouth and Central America continuous positive airway pressure (CPAP) devices market. Moreover, growing CPAP adherence along with the increasing prevalence of respiratory disorders and product launches and technological advancements in CPAP devices is propelling the SCAM CPAP market. However, the no medical coverage for CPAP therapy and high cost associated with the therapy are expected to restrain the growth of the market during the forecast period.
The continuous positive airway pressure devices market is expected to witness significant growth opportunities due to the consistent introduction of new capabilities designed to meet patient'srequirements. For instance, in May 2017, Fisher & Paykel Healthcare Corporation Limited announced the release of F&P SleepStyle™, a CPAP device used in the treatment of obstructive sleep apnea (OSA). The device includes the ThermoSmart humidification, featuring a heated breathing tube o minimise condensation, and SensAwake, which detects wakefulness and automatically reduces treatment pressure to a comfortable level. Specific highlights incorporate an easy-access chamber, user-friendly menu, built-in options, menu buttons, and a quiet, integrated design. Moreover, in September 2020, ResMed launched its first continuous positive airway pressure (CPAP) nasal mask with a memory foam cushion, the AirTouch N20. According to ResMed, it is the softest nasal mask to date. This product uses the patented UltraSoft memory foam cushion, which is also used with the full face AirTouch F20 mask.Technological advancements in CPAP technology helps improve the therapy experience for patients with sleep apnea, which is likely to drive the demand for continuous positive airway pressure devices.CPAP devices come with data storage capabilities, which helpproduce better clinical outcomes with greater accuracy.
Rising prevalence of COVID-19 casesextensive more use of ventilator for the critical patients are leading to the growth of CPAP devices market in the region. In June 2020, the total number of COVID-19 cases and deaths in Brazil was1,151,479 and 52,771 respectively. Brazil is the second most-affected country afterthe US, which accounts for nearly 120,000 deaths and more than 2.2 million cases. Countries such as Argentina and Brazil have responded to the pandemic by closing borders, ordering quarantines, and imposing a host of restrictions to keep people indoors and mitigate the disease spread. Thus, owing to the above-mentioned factors, it is expected that the continuous positive airway pressure (CPAP) devices market is likely to grow in the coming years.
Based on the end user, the South & Central America continuous positive airway pressure (CPAP) devices marketis segmented intohospitals and emergency health departments.The hospitalssegment held a larger share of the market in 2019 and is anticipated to register a higher CAGR in the market during the forecast period.
Based ontype, the South & Central Americacontinuous positive airway pressure (CPAP) devices marketis segmented into automatic and manual. In 2019,the automaticsegment held a larger share of the market andis anticipated to register a higher CAGR in the market during the forecast period.
Some of the major primary and secondary sources for South & Central Americacontinuous positive airway pressure (CPAP) devices market included in the report areNational Center for Biotechnology Information, the World Health Organization (WHO), and United Nations Population Fund (UNFPA).
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America continuous positive airway pressure (CPAP) devices market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America continuous positive airway pressure (CPAP) devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.